Boston Scientific : Position on FDA Update About Use of Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease
On July 11, 2023, the U.S. Food and Drug Administration published a letter to healthcare providers stating that, based on its review of the totality of the available data and analyses,...
Source: marketscreener.com